Latest Patent Technology News

Proteomics International’s subsidiary OxiDx has unveiled a pioneering test that detects muscle damage in thoroughbred racehorses, promising to transform recovery management in the racing industry. The test’s commercial launch is slated for the second half of 2025.

Paradigm Biopharmaceuticals has acquired Proteobioactives, securing global rights to an oral combination therapy targeting early-stage osteoarthritis in humans and animals, complementing its injectable PPS phase 3 program.

Sparc Technologies has unveiled its first-of-its-kind photocatalytic water splitting pilot plant at the University of Adelaide, marking a key milestone in green hydrogen innovation. Commissioning is set to begin in July 2025, aiming to demonstrate a low-cost, modular alternative to traditional electrolysis.

Ionic Rare Earths is advancing plans for multiple magnet recycling plants in the US, leveraging patented technology to produce high-purity rare earth oxides amid growing demand for sovereign supply chains.

IperionX has secured a significant U.S. Department of Defense contract worth up to US$99 million to supply low-cost, high-performance titanium components, marking a major step in reshoring critical materials manufacturing.

Sparc Technologies is progressing its innovative green hydrogen pilot plant and graphene-based anti-corrosion trials, supported by a recent A$2.7 million capital raise to accelerate commercialisation and R&D.

Adisyn Ltd has completed its transformative acquisition of 2D Generation, securing a $10 million capital raise to accelerate development of graphene-enhanced semiconductor technologies. The company is positioning itself to disrupt key markets including defence, data centres, and cybersecurity.